Cerebroplacental Ratio (CPR) and Amniotic-Umbilical-to-Cerebral Ratio (AUCR), in in Women With Hypertensive Disorders of Pregnancy.

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-40
SponsorAssiut University

About this trial

The primary aim of this study is to evaluate the predictive value of the Amniotic-Umbilical-to-Cerebral Ratio (AUCR) in predicting composite adverse perinatal outcomes in women with hypertensive disorders of pregnancy and to compare its predictive performance with the traditional Cerebroplacental Ratio (CPR)

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Women aged 18-40 years, inclusive.

Singleton viable pregnancy.

Gestational age ≥32 weeks.

Pregnancy complicated by a hypertensive disorder.

Disqualifiers

Multiple gestation.

Fetuses with known chromosomal or major congenital anomalies.

Maternal diseases likely to independently affect fetal circulation or perinatal outcome, such as significant cardiac disease or other major systemic diseases.

Inability to complete the required follow-up.

Trial population

pregnant women with hypertensive disorder

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

130 Participants
are grouped into 1 trial group
Group A: obstetric doppler indices in hypertensive disorder with pregnancy

Trial outcomes

Primary outcomes

1

number of cases with NICU admission

number of neonates admitted in neonatal care unit within 24 hours after delivery

Time frame
6 weeks

Secondary outcomes

1

weight of birth

birth weight in grams after delivery

Time frame
1 day

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: